Roles of IL-11 in the Regulation of Bone Metabolism

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Feb 14

PMID 38352248

Authors

Yijing Han

Hui Gao

Xinling Gan

Jingying Liu

Chuncha Bao

Chengqi He

Affiliations

Soon will be listed here.

Abstract

Bone metabolism is the basis for maintaining the normal physiological state of bone, and imbalance of bone metabolism can lead to a series of metabolic bone diseases. As a member of the IL-6 family, IL-11 acts primarily through the classical signaling pathway IL-11/Receptors, IL-11 (IL-11R)/Glycoprotein 130 (gp130). The regulatory role of IL-11 in bone metabolism has been found earlier, but mainly focuses on the effects on osteogenesis and osteoclasis. In recent years, more studies have focused on IL-11's roles and related mechanisms in different bone metabolism activities. IL-11 regulates osteoblasts, osteoclasts, BM stromal cells, adipose tissue-derived mesenchymal stem cells, and chondrocytes. It's involved in bone homeostasis, including osteogenesis, osteolysis, bone marrow (BM) hematopoiesis, BM adipogenesis, and bone metastasis. This review exams IL-11's role in pathology and bone tissue, the cytokines and pathways that regulate IL-11 expression, and the feedback regulations of these pathways.

Citing Articles

High-intensity ethanol binge drinking accentuates bone damage in induced apical periodontitis in rats.

Matos-Sousa J, Souza-Monteiro D, Dos Santos V, Ferreira M, Frazao D, Chemelo V Heliyon. 2024; 10(22):e40163.

PMID: 39641066 PMC: 11617731. DOI: 10.1016/j.heliyon.2024.e40163.

Role of microRNA in Diabetic Osteoporosis.

Yuan Q, Wang Y, Hu S, Cai Z, Jiang L, Huang Y Mol Biotechnol. 2024; .

PMID: 39609335 DOI: 10.1007/s12033-024-01316-1.

The JAK-STAT pathway: from structural biology to cytokine engineering.

Lv Y, Qi J, Babon J, Cao L, Fan G, Lang J Signal Transduct Target Ther. 2024; 9(1):221.

PMID: 39169031 PMC: 11339341. DOI: 10.1038/s41392-024-01934-w.

Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments.

Dawalibi A, Alosaimi A, Mohammad K Int J Mol Sci. 2024; 25(15).

PMID: 39125732 PMC: 11311339. DOI: 10.3390/ijms25158163.

Interleukin-19 in Bone Marrow Contributes to Bone Loss Via Suppressing Osteogenic Differentiation Potential of BMSCs in Old Mice.

He E, Sui H, Wang H, Zhao X, Guo W, Dai Z Stem Cell Rev Rep. 2024; 20(5):1311-1324.

PMID: 38502291 DOI: 10.1007/s12015-024-10709-3.

References

Lim W, Ng B, Widjaja A, Xie C, Su L, Ko N . Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice. PLoS One. 2020; 15(1):e0227505. PMC: 6952089. DOI: 10.1371/journal.pone.0227505. View

Taipaleenmaki H . Regulation of Bone Metabolism by microRNAs. Curr Osteoporos Rep. 2018; 16(1):1-12. DOI: 10.1007/s11914-018-0417-0. View

Siddappa R, Martens A, Doorn J, Leusink A, Olivo C, Licht R . cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo. Proc Natl Acad Sci U S A. 2008; 105(20):7281-6. PMC: 2387183. DOI: 10.1073/pnas.0711190105. View

Suga K, Saitoh M, Kokubo S, Fukushima S, Kaku S, Yasuda S . Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. J Interferon Cytokine Res. 2003; 23(4):203-7. DOI: 10.1089/107999003765027401. View

Sims N, Walsh N . GP130 cytokines and bone remodelling in health and disease. BMB Rep. 2010; 43(8):513-23. DOI: 10.5483/bmbrep.2010.43.8.513. View

Chen Q, Rabach L, Noble P, Zheng T, Lee C, Homer R . IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J Immunol. 2005; 174(4):2305-13. DOI: 10.4049/jimmunol.174.4.2305. View

Ng B, Dong J, DAgostino G, Viswanathan S, Widjaja A, Lim W . Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci Transl Med. 2019; 11(511). DOI: 10.1126/scitranslmed.aaw1237. View

Maze R, Moritz T, Williams D . Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11. Cancer Res. 1994; 54(18):4947-51. View

Shurin M, Esche C, Lotze M . FLT3: receptor and ligand. Biology and potential clinical application. Cytokine Growth Factor Rev. 1998; 9(1):37-48. DOI: 10.1016/s1359-6101(97)00035-x. View

10.

Shaughnessy S, Walton K, Deschamps P, Butcher M, Beaudin S . Neutralization of interleukin-11 activity decreases osteoclast formation and increases cancellous bone volume in ovariectomized mice. Cytokine. 2002; 20(2):78-85. DOI: 10.1006/cyto.2002.1981. View

11.

Sammel M, Peters F, Lokau J, Scharfenberg F, Werny L, Linder S . Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP. Int J Mol Sci. 2019; 20(15). PMC: 6696353. DOI: 10.3390/ijms20153677. View

12.

Angeli A, Dovio A, Sartori M, Masera R, Ceoloni B, Prolo P . Interactions between glucocorticoids and cytokines in the bone microenvironment. Ann N Y Acad Sci. 2002; 966:97-107. DOI: 10.1111/j.1749-6632.2002.tb04207.x. View

13.

Zhu M, Lu B, Cao Q, Wu Z, Xu Z, Li W . IL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice. PLoS One. 2015; 10(5):e0126296. PMC: 4422694. DOI: 10.1371/journal.pone.0126296. View

14.

Kokebie R, Aggarwal R, Lidder S, Hakimiyan A, Rueger D, Block J . The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther. 2011; 13(2):R50. PMC: 3132039. DOI: 10.1186/ar3293. View

15.

Zhu Z, Lee C, Zheng T, Chupp G, Wang J, Homer R . Airway inflammation and remodeling in asthma. Lessons from interleukin 11 and interleukin 13 transgenic mice. Am J Respir Crit Care Med. 2001; 164(10 Pt 2):S67-70. DOI: 10.1164/ajrccm.164.supplement_2.2106070. View

16.

Romas E, Udagawa N, Zhou H, Tamura T, Saito M, Taga T . The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J Exp Med. 1996; 183(6):2581-91. PMC: 2192607. DOI: 10.1084/jem.183.6.2581. View

17.

Howlett M, Giraud A, Lescesen H, Jackson C, Kalantzis A, van Driel I . The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Gastroenterology. 2009; 136(3):967-77. DOI: 10.1053/j.gastro.2008.12.003. View

18.

Walton K, Duncan J, Deschamps P, Shaughnessy S . Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation. Blood. 2002; 100(7):2530-6. DOI: 10.1182/blood.V100.7.2530. View

19.

Annamalai D, Clipstone N . Prostaglandin F2α inhibits adipogenesis via an autocrine-mediated interleukin-11/glycoprotein 130/STAT1-dependent signaling cascade. J Cell Biochem. 2014; 115(7):1308-21. DOI: 10.1002/jcb.24785. View

20.

Pasqualini R, Millikan R, Christianson D, Cardo-Vila M, Driessen W, Giordano R . Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study. Cancer. 2015; 121(14):2411-21. PMC: 4490036. DOI: 10.1002/cncr.29344. View